###begin article-title 0
The First Cellular Models Based on Frataxin Missense Mutations That Reproduce Spontaneously the Defects Associated with Friedreich Ataxia
###end article-title 0
###begin p 1
Conceived and designed the experiments: NC SS HMP. Performed the experiments: NC SS MWD AM NV LR NM CB. Analyzed the data: NC SS HMP. Wrote the paper: NC SS AM MK HMP.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 244 245 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 209 217 <span type="species:ncbi:9606">patients</span>
###xml 308 316 <span type="species:ncbi:9606">patients</span>
Friedreich ataxia (FRDA), the most common form of recessive ataxia, is due to reduced levels of frataxin, a highly conserved mitochondrial iron-chaperone involved in iron-sulfur cluster (ISC) biogenesis. Most patients are homozygous for a (GAA)n expansion within the first intron of the frataxin gene. A few patients, either with typical or atypical clinical presentation, are compound heterozygous for the GAA expansion and a micromutation.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 516 521 516 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 530 535 530 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 754 759 754 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 45 51 <span type="species:ncbi:10090">murine</span>
###xml 192 198 <span type="species:ncbi:10090">murine</span>
###xml 280 285 <span type="species:ncbi:9606">human</span>
###xml 331 337 <span type="species:ncbi:10090">murine</span>
###xml 477 482 <span type="species:ncbi:9606">human</span>
###xml 1019 1027 <span type="species:ncbi:9606">patients</span>
We have developed a new strategy to generate murine cellular models for FRDA: cell lines carrying a frataxin conditional allele were used in combination with an EGFP-Cre recombinase to create murine cellular models depleted for endogenous frataxin and expressing missense-mutated human frataxin. We showed that complete absence of murine frataxin in fibroblasts inhibits cell division and leads to cell death. This lethal phenotype was rescued through transgenic expression of human wild type as well as mutant (hFXNG130V and hFXNI154F) frataxin. Interestingly, cells expressing the mutated frataxin presented a FRDA-like biochemical phenotype. Though both mutations affected mitochondrial ISC enzymes activities and mitochondria ultrastructure, the hFXNI154F mutant presented a more severe phenotype with affected cytosolic and nuclear ISC enzyme activities, mitochondrial iron accumulation and an increased sensitivity to oxidative stress. The differential phenotype correlates with disease severity observed in FRDA patients.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 177 184 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
These new cellular models, which are the first to spontaneously reproduce all the biochemical phenotypes associated with FRDA, are important tools to gain new insights into the in vivo consequences of pathological missense mutations as well as for large-scale pharmacological screening aimed at compensating frataxin deficiency.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 246 249 246 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Harding1">[1]</xref>
###xml 251 254 251 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Ribai1">[2]</xref>
###xml 331 334 331 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Campuzano1">[3]</xref>
###xml 722 725 722 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Pandolfo1">[4]</xref>
###xml 989 992 989 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Rotig1">[5]</xref>
###xml 993 996 993 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Seznec1">[9]</xref>
###xml 1125 1129 1125 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Adinolfi1">[10]</xref>
###xml 886 891 <span type="species:ncbi:9606">human</span>
###xml 893 898 <span type="species:ncbi:10090">mouse</span>
###xml 903 908 <span type="species:ncbi:4932">yeast</span>
Friedreich ataxia (FRDA), the most common hereditary ataxia, is an autosomal recessive neurodegenerative disease characterized by progressive gait and limb ataxia associated with hypertrophic cardiomyopathy and an increased incidence of diabetes [1], [2]. FRDA is caused by reduced expression of the mitochondrial protein frataxin [3]. The physiopathological consequences of frataxin deficiency are a severe disruption of Fe-S cluster biosynthesis, mitochondrial iron overload coupled to cellular iron dysregulation, and possibly an increased sensitivity to oxidative stress. Frataxin is a highly conserved protein which has been suggested to participate in a variety of pathways associated with cellular iron homeostasis [4]. However, only its essential role as a mitochondrial iron-chaperone for iron-sulfur cluster (ISC) biogenesis is widely accepted. Indeed, frataxin deficiency in human, mouse and yeast leads to severe alteration of mitochondrial and extramitochondrial ISC proteins [5]-[9]. Very recently, the bacterial frataxin has been proposed to be an iron sensor that act as a regulator of Fe-S cluster formation [10].
###end p 9
###begin p 10
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 123 126 123 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Campuzano1">[3]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Sakamoto1">[11]</xref>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Saveliev1">[12]</xref>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Busi1">[13]</xref>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Cossee1">[14]</xref>
###xml 758 768 758 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. elegans</italic>
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Ventura1">[15]</xref>
###xml 861 871 861 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 871 875 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Anderson1">[16]</xref>
###xml 877 881 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Llorens1">[17]</xref>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 758 768 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
###xml 861 871 <span type="species:ncbi:7227">Drosophila</span>
The most common mutation leading to FRDA is a (GAA)n triplet repeat expansion within the first intron of the frataxin gene [3]. 96% of patients carry two expanded alleles which lead to a partial transcriptional silencing, either through the formation of a triple helix which interferes with transcriptional elongation [11] or epigenetic changes leading to heterochromatin formation thereby impairing gene transcription [12]. This results in a strongly reduced frataxin protein expression in all tissues. This partial silencing is of importance as in multicellular eukaryotes, frataxin is essential for embryonic development. Indeed, complete frataxin deletion leads to early embryonic lethality in plants and mice [13], [14], to L2/L3 larval stage arrest in C. elegans[15], and to reduced larval viability and metamorphosis failure by systemic silencing in the Drosophila[16], [17].
###end p 10
###begin p 11
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Cossee2">[18]</xref>
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Gellera1">[19]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-DhePaganon1">[20]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Musco1">[21]</xref>
###xml 577 580 577 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Campuzano1">[3]</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Cossee2">[18]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Gellera1">[19]</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Filla1">[22]</xref>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Cossee2">[18]</xref>
###xml 902 906 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Bidichandani1">[23]</xref>
###xml 907 911 907 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-McCabe1">[25]</xref>
###xml 1235 1239 1235 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Cossee2">[18]</xref>
###xml 1241 1245 1241 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-McCabe1">[25]</xref>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
###xml 532 540 <span type="species:ncbi:9606">patients</span>
###xml 635 643 <span type="species:ncbi:9606">patients</span>
###xml 675 683 <span type="species:ncbi:9606">patients</span>
###xml 867 875 <span type="species:ncbi:9606">patients</span>
###xml 997 1005 <span type="species:ncbi:9606">patients</span>
###xml 1169 1177 <span type="species:ncbi:9606">patients</span>
A small but significant number of FRDA patients (4%) are compound heterozygous for the (GAA)n expansion and a micromutation [18], [19]. Out of the 40 pathogenic sequence variants reported in frataxin, at least 15 missense point mutations have been described. There are a few prevalent mutations that result either in classical FRDA phenotype (I154F and W155R) or an atypical clinical presentation (G130V). Isoleucine 154 is a hydrophobic residue involved in the protein core [20], [21]. The I154F mutation has been described in six patients from four families from South Italy [3], [18], [19], [22]. The clinical presentation of these patients is indistinguable from that of patients homozygous for the expansion. The G>T transversion at nucleotide 389 leading to the G130V replacement is the most frequent missense mutation in FRDA, found in more than ten Caucasian patients from five families ([18], [23]-[25] and MK unpublished data). Although the age of onset is within the first ten years in patients carrying the G130V mutations, disease progression is remarkably slow. The absence of dysarthria and the persistence of knee jerks are consistent findings in these patients. A more spastic than ataxic gait has also been described [18], [25].
###end p 11
###begin p 12
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Lu1">[26]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Zanella1">[30]</xref>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Lu1">[26]</xref>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Stehling1">[28]</xref>
###xml 629 633 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Zanella1">[30]</xref>
###xml 159 166 <span type="species:ncbi:9606">patient</span>
###xml 419 424 <span type="species:ncbi:9606">human</span>
###xml 429 435 <span type="species:ncbi:10090">murine</span>
###xml 698 706 <span type="species:ncbi:9606">patients</span>
###xml 787 793 <span type="species:ncbi:10090">murine</span>
###xml 820 825 <span type="species:ncbi:9606">human</span>
Mammalian cell models are important to study the molecular mechanisms of disease and are powerful tools for large-scale therapeutical screening approaches. As patient's cell line (fibroblasts or lymphocytes) do not express consistently the biochemical phenotypes associated with FRDA under basal cultured conditions, RNA interference [26]-[30] strategies have been developed to reproduce partial frataxin deficiency in human and murine cell lines. A few models exhibit some of the biochemical features associated with FRDA, notably the deficiency in ISC biosynthesis and the increased sensitivity to oxidative stress [26], [28], [30], but none reproduce the mitochondrial iron accumulation seen in patients. In the present work, we developed novel cellular models deleted for endogenous murine frataxin and expressing a human frataxin cDNA carrying pathogenic missense mutations resulting in a classical (I154F) and an atypical (G130V) FRDA clinical presentation. The models obtained are the first stable cellular models that reproduce spontaneously all the biochemical phenotype associated with FRDA.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 30 36 <span type="species:ncbi:10090">murine</span>
Complete frataxin deletion in murine fibroblasts is not viable and can be rescued by transgenic expression of mFxn
###end title 14
###begin p 15
###xml 378 383 378 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-</sup>
###xml 385 388 385 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Puccio1">[7]</xref>
###xml 390 397 390 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g001">Fig. 1A</xref>
###xml 765 772 765 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g001">Fig. 1B</xref>
###xml 861 866 861 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L-/L-</sup>
###xml 877 884 877 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g001">Fig. 1B</xref>
###xml 21 29 <span type="species:ncbi:9606">patients</span>
###xml 217 222 <span type="species:ncbi:10090">mouse</span>
###xml 316 321 <span type="species:ncbi:10090">mouse</span>
Since fibroblasts of patients with mutations directly affecting the respiratory chain are viable in cell culture, irrespective of viability in the animal, we sought to obtain a FRDA cell model by frataxin deletion in mouse fibroblasts. To this end, an immortalized fibroblast cell line compound heterozygous for the mouse frataxin conditional allele and the deleted allele (FrdaL3/L-) [7] (Fig. 1A) was transfected with a fluorescent recombinase (pEGFP-Cre) and sorted by FACS 48 hours after transfection. Most sorted cells stopped dividing after 2-3 days in culture, became round, to end up floating in the culture medium after 7-10 days in culture. The genotype of the total cellular population demonstrated that not all adherent cells were deleted for frataxin (Fig. 1B, lane 4), while the floating cells harvested from the supernatant presented a clear FrdaL-/L- genotype (Fig. 1B, lane 5) suggesting that complete frataxin deletion is lethal in fibroblast.
###end p 15
###begin title 16
###xml 51 57 <span type="species:ncbi:10090">murine</span>
Frataxin is essential for division and survival of murine fibroblasts.
###end title 16
###begin p 17
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 114 116 114 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3</sup>
###xml 159 161 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L-</sup>
###xml 218 221 218 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Puccio1">[7]</xref>
###xml 257 262 257 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-</sup>
###xml 381 386 381 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-</sup>
###xml 474 479 474 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L-/L-</sup>
###xml 586 591 586 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-</sup>
###xml 705 717 705 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; empty</sup>
###xml 791 802 791 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; mFxn</sup>
###xml 940 945 940 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-</sup>
###xml 1068 1079 1068 1079 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; mFxn</sup>
###xml 1182 1194 1182 1194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; empty</sup>
###xml 41 47 <span type="species:ncbi:10090">murine</span>
###xml 759 765 <span type="species:ncbi:10090">murine</span>
###xml 1026 1032 <span type="species:ncbi:10090">murine</span>
A. Schematic representation of wild-type murine frataxin allele (Frda+), the loxP-flanked Frda exon 4 allele (FrdaL3) and the Cre-mediated deleted allele (FrdaL-). Primers used for genotyping are represented by arrows [7]. B. Genotyping on heterozygous FrdaL3/L- cells before (lane 3) and after (lanes 4 and 5) pEGFP-Cre transfection and sort. Adherent living cells display a Frda L3/L-, Cre genotype (lane 4) whereas floating cells are completely deleted for frataxin (FrdaL-/L-) (lane 5). Lane 2: positive controls of each PCR. Lane 1: negative control (no DNA). C. Genotyping of FrdaL3/L- clones after pEGFP-Cre transfection and sort. Results from one clone transfected with an empty vector (pSG5: FrdaL3/L-; empty, clone B7) and two clones overexpressing murine frataxin (pSG5-mFxn: FrdaL3/L-; mFxn, clones C10 and E2). First lane: no DNA (-). Second lane: positive controls of each PCR (+). D. Phase contrast microscopy on rescued FrdaL3/L- clones after pEGFP-Cre transfection and sort. pSG5-mFxn: normal morphology of a murine frataxin overexpressing clone (FrdaL3/L-; mFxn) and deleted for endogenous frataxin. pSG5: cells from a clone transfected with the empty vector (FrdaL3/L-; empty). Note the presence of many elongated or round unhealthy cells. Phase contrast (20x magnification), cells plated in 96-well plastic plates.
###end p 17
###begin p 18
###xml 242 247 242 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-</sup>
###xml 263 274 263 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; mFxn</sup>
###xml 512 523 512 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; mFxn</sup>
###xml 707 718 707 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; mFxn</sup>
###xml 783 790 783 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g001">Fig. 1C</xref>
###xml 852 871 852 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g001">Fig. 1D, left panel</xref>
###xml 1093 1100 1093 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006379.s002">Fig. S1</xref>
###xml 1188 1198 1188 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-;pSG5</sup>
###xml 1371 1391 1371 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g001">Fig. 1D, right panel</xref>
###xml 1627 1629 1627 1629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3</sup>
###xml 1672 1674 1672 1674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L-</sup>
###xml 1703 1710 1703 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g001">Fig. 1C</xref>
###xml 2041 2052 2041 2052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; pSG5</sup>
###xml 2068 2075 2068 2075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006379.s003">Fig. S2</xref>
###xml 135 141 <span type="species:ncbi:10090">murine</span>
###xml 687 692 <span type="species:ncbi:10090">mouse</span>
To confirm that frataxin deletion is the cause of cell detachment and subsequent death, we determined whether transgenic expression of murine frataxin (mFxn) could rescue the phenotype. The mFxn cDNA (pSG5-mFxn) was stably expressed into FrdaL3/L- cell line (FrdaL3/L-; mFxn). Western blot analysis confirmed a three fold increase in frataxin protein compared to endogenous levels with no effect on the general morphology of the cell lines (data not shown). pEGFP-Cre transfection was then performed on both FrdaL3/L-; mFxn and control cell lines. Transfected cells were sorted by FACS one cell per well and the clones were cultured for seven to ten days. Nineteen clones overexpressing mouse frataxin (FrdaL3/L-; mFxn) presented a complete deletion of the endogenous frataxin gene (Fig. 1C, clones C10 and E2). All clones displayed normal morphology (Fig. 1D, left panel) and growth, demonstrating that transgenic expression of frataxin rescues the lethality associated with complete deficiency of endogenous frataxin. Frataxin protein overexpression was confirmed in several deleted clones (Fig. S1). Only five clones were obtained from the cells transfected with the empty vector (FrdaL3/L-;pSG5). These clones exhibited an abnormal morphology with a few dozen spindle-shaped fibroblasts, which became round and barely attached to the plate after 5-7 days of culture (Fig. 1D, right panel). These clones clearly stopped dividing. Genotyping of the five unhealthy clones performed on the total cell lysates (DNA extraction was avoided due to the small amount of cells) was successful in only three cases: the conditional FrdaL3 allele was converted into the deleted FrdaL- allele in all three clones (Fig. 1C, clone B7). Frataxin protein deficiency could not be evaluated by western blot as too few cells were available. In electron microscopy studies, apart from the retraction of the plasma membrane leading to an organelle dense cytoplasm, no structural anomaly in the mitochondria nor sign of necrosis or apoptosis was detected in FrdaL3/L-; pSG5 sorted clones (Fig. S2). Together, these results confirm the deleterious consequence of frataxin deficiency on cell proliferation and survival.
###end p 18
###begin title 19
Transgenic expression of pathological hFXN mutants partially rescues the endogenous frataxin deficiency
###end title 19
###begin p 20
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 317 322 317 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-</sup>
###xml 338 349 338 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; hFXN</sup>
###xml 355 367 355 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; G130V</sup>
###xml 373 385 373 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; I154F</sup>
###xml 556 563 556 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g002">Fig. 2A</xref>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:9606">human</span>
###xml 236 241 <span type="species:ncbi:9606">human</span>
We sought to use this newly developed ex vivo system as a novel tool to generate cell models expressing a human frataxin cDNA carrying pathogenic missense mutations. The wild type human frataxin (hFXN) cDNA (pcDNA-hFXN) and both mutant human frataxin cDNA (pcDNA-G130V and pcDNA-I154F) were stably expressed into FrdaL3/L- cell line (FrdaL3/L-; hFXN; FrdaL3/L-; G130V; FrdaL3/L-; I154F). Quantitative RT-PCR (not shown) and western blot analysis confirmed the expression and correct mitochondrial targeting and maturation of the three frataxin constructs (Fig. 2A, lanes 4, 7 and 10).
###end p 20
###begin title 21
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
Murine frataxin (mFxn) deficiency and human frataxin (hFXN) expression in the missense mutants.
###end title 21
###begin p 22
###xml 530 534 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Frda</italic>
###xml 534 539 534 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-</sup>
###xml 587 592 587 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-</sup>
###xml 682 693 682 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; hFXN</sup>
###xml 699 711 699 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; G130V</sup>
###xml 717 729 717 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; I154F</sup>
###xml 194 199 <span type="species:ncbi:9606">human</span>
###xml 204 210 <span type="species:ncbi:10090">murine</span>
###xml 293 299 <span type="species:ncbi:10090">murine</span>
###xml 335 340 <span type="species:ncbi:9606">human</span>
###xml 383 388 <span type="species:ncbi:9606">human</span>
###xml 399 405 <span type="species:ncbi:10090">Murine</span>
###xml 410 415 <span type="species:ncbi:9606">human</span>
###xml 477 483 <span type="species:ncbi:10090">murine</span>
A. Western Blot analysis on mitochondria-enriched fractions using anti-frataxin (R1270 and 1G2) and anti-MnSOD antibodies. hFXN and mFxn lanes correspond to COS cells transfected with wild-type human and murine frataxin expression vector, respectively. The R1270 antibody was designed against murine frataxin but cross-reacts with the human protein. The 1G2 antibody recognizes only human frataxin. Murine and human frataxin were separated using a long SDS-PAGE gel. Note that murine frataxin was detected as a two-band signal in FrdaL3/L- fibroblasts. B. Genotyping on heterozygous FrdaL3/L- cell populations expressing either wild type or mutant (G130V or I154F) hFXN before (FrdaL3/L-; hFXN; FrdaL3/L-; G130V; FrdaL3/L-; I154F) and after (hFXN, G130V and I154F clones, three different clones for each) pEGFP-Cre transfection and clonal sorting. First lane: positive controls of each PCR (+). Last lane: no DNA (-).
###end p 22
###begin p 23
###xml 160 171 160 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; hFXN</sup>
###xml 177 189 177 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; G130V</sup>
###xml 198 210 198 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-; I154F</sup>
###xml 283 288 283 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-</sup>
###xml 521 526 521 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 535 540 535 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 549 556 549 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g002">Fig. 2B</xref>
###xml 720 727 720 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g002">Fig. 2A</xref>
###xml 867 872 867 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 881 886 881 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 897 904 897 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g002">Fig. 2A</xref>
###xml 1016 1021 1016 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1063 1068 1063 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 25 31 <span type="species:ncbi:10090">murine</span>
###xml 452 458 <span type="species:ncbi:10090">murine</span>
###xml 642 647 <span type="species:ncbi:10090">mouse</span>
###xml 704 710 <span type="species:ncbi:10090">murine</span>
###xml 1220 1225 <span type="species:ncbi:9606">human</span>
To delete the endogenous murine frataxin, pEGFP-Cre transfection and clonal sorting was performed. After the sort, 13, 6 and 3 clones were obtained for the FrdaL3/L-; hFXN, FrdaL3/L-; G130V and FrdaL3/L-; I154F cell lines, respectively. As a control, similar experiments with an FrdaL3/L- cell line stably transfected with a truncated form of hFXN (exon 1 and 2 only) resulted in no clone. Genotyping demonstrated a complete deletion of the endogenous murine frataxin gene for each clone, hereafter referred as hFXN, hFXNG130V and hFXNI154F clones (Fig. 2B). Quantitative RT-PCR and western blot analysis confirmed deletion of the endogenous mouse frataxin transcript (data not shown) and absence of the murine protein (Fig. 2A) in each clone. Western blot analysis of mitochondria-enriched fractions of the different clones demonstrated proper maturation of the hFXNG130V and hFXNI154F proteins (Fig. 2A, lanes 8-9 and 11-12, respectively). Interestingly, all I154F clones showed a high expression level of the hFXNI154F protein compared to the wild-type or hFXNG130V proteins, correlating with a 4-10 fold increased level of the transcript (data not shown). All clones showed sustained growth, demonstrating that each human construct was able to rescue the lethal phenotype.
###end p 23
###begin title 24
New "humanized" cell models for FRDA based on the missense mutations
###end title 24
###begin p 25
###xml 172 177 172 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 535 540 535 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 691 697 691 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g003">Fig. 3</xref>
###xml 724 729 724 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 827 833 827 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g003">Fig. 3</xref>
###xml 844 849 844 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 902 907 902 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1072 1078 1072 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g003">Fig. 3</xref>
###xml 1090 1095 1090 1095 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1108 1113 1108 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1215 1220 1215 1220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1327 1333 1327 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g003">Fig. 3</xref>
All isolated clones were viable and proliferated over multiple passages in classical culture conditions. However, compared to the clones expressing wild type hFXN, the hFXNI154F expressing clones repeatedly showed a growth defect, taking a longer time to reach confluence. This growth defect was particularly noticeable after strong dilution of the cell line. Although consistent, the growth defect was not sufficiently severe to cause a significant difference over a 4-day proliferation curve (data not shown). Interestingly, the hFXNG130V expressing clones did not show any growth defect. Furthermore, while the clones expressing the wild type hFXN presented normal fibroblast morphology (Fig. 3, line hFXN-1D12), the hFXNG130V expressing clones displayed a slightly altered morphology with smaller or less spread out cells (Fig. 3, line hFXNG130V-G4). In correlation with the growth defect, the hFXNI154F expressing clones displayed a very altered morphology, with numerous small grainy rounded cells with a retracted cytoplasm and some elongated spindle-shaped cells (Fig. 3, lines hFXNI154F-1D3 and hFXNI154F-2C1). Finally, gigantic cells reminiscent of senescence features were also observed in the three hFXNI154F expressing clones. These cells were spread out and exhibited fractionated nucleus and cytosolic vacuoles (Fig. 3, line I154F-1D3).
###end p 25
###begin title 26
Altered morphology of frataxin mutated clones.
###end title 26
###begin p 27
###xml 88 93 88 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 132 137 132 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 150 155 150 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 25 30 <span type="species:ncbi:9606">human</span>
Morphology of one normal human frataxin clone (hFXN-1D12), one G130V mutated clone (hFXNG130V-G4) and two I154F mutated clones (hFXNI154F-1D3 and hFXNI154F-2C1) were studied by phase contrast microscopy after crystal violet staining. The scale represents 50 microm in A and 25 microm in B. n, normally spread fibroblast; ls, less spread cell; r, rounded cell; ss, spindle-shaped cell; s, senescent cell.
###end p 27
###begin p 28
###xml 64 69 64 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 78 83 78 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 225 230 225 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 239 244 239 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 362 370 362 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g004">Figs. 4A</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006379.s004">S3</xref>
###xml 520 525 520 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 534 539 534 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 762 769 762 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g004">Fig. 4A</xref>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006379.s004">S3</xref>
###xml 910 915 910 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1114 1121 1114 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g004">Fig. 4A</xref>
###xml 1182 1187 1182 1187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 1233 1238 1233 1238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1446 1451 1446 1451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1525 1532 1525 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g004">Fig. 4B</xref>
###xml 1688 1695 1688 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006379.s005">Fig. S4</xref>
###xml 1768 1773 1768 1773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1830 1837 1830 1837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006379.s005">Fig. S4</xref>
###xml 2034 2035 2034 2035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 722 727 <span type="species:ncbi:4679">onion</span>
###xml 1982 1987 <span type="species:ncbi:9606">human</span>
The ultrastructural analysis by electron microscopy of both hFXNG130V and hFXNI154F clones revealed strongly altered mitochondrial morphology with little damage to other components of the cell. At the cellular level, the hFXNG130V and hFXNI154F clones presented cytoplasmic blebbing, an ultrastructural sign of reversible cell injury, and increased pseudopodia (Figs. 4A and S3). While abnormal mitochondria were rare events in the wild-type hFXN clones, several alterations of the mitochondria were observed in the hFXNG130V and hFXNI154F clones. Only few mitochondria appeared intact with normal cristae membranes, and many showed spherical shape, either lacking cristae membranes, exhibiting central tubular cristae or onion-shaped inner membrane structures (Fig. 4A and S3). Interestingly, a significant number of giant disorganised mitochondria, derived from mitochondrial fusion, was observed in the hFXNI154F clones. It is important to note that some intramitochondrial electron-dense deposits consistent with iron accumulation were detected in both clones, often associated to the mitochondrial membranes (Fig. 4A). While small deposits were detected in only 10% of the hFXNG130V cells, more than 50% of the cells in the hFXNI154F clones presented several mitochondria with large intramitochondrial deposits. Direct measurements of the iron content of mitochondrial-enriched fraction of the different cell lines demonstrated that the hFXNI154F clones present a two fold iron accumulation compared to the hFXN clones (Fig. 4B). By atomic absorption spectroscopy, the iron content of the soluble mitochondrial fraction showed a slight but not significant increased in iron content (Fig. S4). However, the iron content of the insoluble membrane pellet of the hFXNI154F clones was 2.3 fold higher compared to the hFXN clones (Fig. S4), further supporting that the electron-dense deposits correspond to iron rich aggregates. As a loss of cristae membranes has been described for human cell that are devoid of mitochondrial DNA (rho0 cells), we checked the integrity of mitochondrial DNA by long-range PCR. No difference was found between the hFXN and mutant clones (data not shown), indicating that these cells did not loose their mitochondrial DNA.
###end p 28
###begin title 29
###xml 51 56 51 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 65 70 65 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
Ultrastructural alterations and iron status in hFXNG130V and hFXNI154F clones.
###end title 29
###begin p 30
###xml 44 49 44 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 508 528 508 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">material and methods</xref>
###xml 228 233 <span type="species:ncbi:4679">onion</span>
A. Electron microscopy on hFXN (i), and hFXNI154F (ii-iv) clones. b, plasma membrane blebbing; g-mt, giant mitochondria; Lp, lipid droplet; mt, mitochondria; mt-Fe, electron-dense intramitochondrial deposits; N, nucleus; os-mt, onion-shaped mitochondria; p, pseudopodia; rer, rough endoplasmic reticulum. B. Determination of iron concentration. Total iron concentration of mitochondrial-enriched fractions of the different clones was assessed spectrophotometrically using bathophenanthroline as described in material and methods. Results are given as mean of nmol of iron per mg of protein in each fraction + SD. * p<0.01.
###end p 30
###begin p 31
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Rotig1">[5]</xref>
###xml 254 257 254 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Puccio1">[7]</xref>
###xml 258 261 258 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Seznec1">[9]</xref>
###xml 286 291 286 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 300 305 300 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 440 445 440 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 474 479 474 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 542 549 542 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g005">Fig. 5A</xref>
###xml 614 619 614 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 628 633 628 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 753 760 753 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g005">Fig. 5A</xref>
###xml 853 857 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Eisenstein1">[31]</xref>
###xml 1149 1154 1149 1154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1194 1201 1194 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g005">Fig. 5B</xref>
###xml 1421 1425 1421 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Ide1">[32]</xref>
###xml 1510 1515 1510 1515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1524 1531 1524 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g005">Fig. 5C</xref>
###xml 1967 1972 1967 1972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 2169 2173 2169 2173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Zhou1">[33]</xref>
###xml 2207 2212 2207 2212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 2221 2226 2221 2226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 2235 2242 2235 2242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g005">Fig. 5D</xref>
###xml 241 246 <span type="species:ncbi:10090">mouse</span>
To assess the consequences of the missense mutations on the ISC-related function of frataxin, the activities of mitochondrial, cytosolic and nuclear ISC containing enzymes known to be decreased in FRDA heart biopsies [5] or FRDA conditional mouse models [7]-[9] were measured. Both hFXNG130V and hFXNI154F clones showed a significant decrease in the mitochondrial succinate dehydrogenase (SDH) activity with a more severe effect in the hFXNI154F mutants compared to the hFXNG130V mutants with 36% and 54% residual SDH activity, respectively (Fig. 5A). The activity of the aconitases was also decreased in both hFXNG130V and hFXNI154F clones, although to a lesser degree than the SDH activity, with 74% and 64% residual aconitase activity, respectively (Fig. 5A). The iron regulatory protein 1 (IRP1) is a bifunctional ISC protein located in the cytosol [31]. In the presence of [4Fe-4S] cluster, it functions as an aconitase. Devoid of its ISC, it binds to specific mRNA stem loop structures called IRE to regulate the expression of proteins involved in iron homeostasis. An increase in the IRE binding activity of IRP1 was measured only in the hFXNI154F clones compared to the parental cells (Fig. 5B). To determine whether there was a deficit in a nuclear ISC protein, we evaluated the activity of Nth1, a [4Fe-4S] glycosylase/AP-lyase involved in the base excision repair of oxidized bases such as thymine glycol (Tg) [32]. A significant decrease in the activity of Nth1was observed specifically in the hFXNI154F clones (Fig. 5C). The change in activity was not due to a transcriptional regulation, as RT-PCR showed no difference in Nth1 expression between the different clones (data not shown). Note that the decrease in the ISC enzymes activities described above occurs spontaneously, without the addition of exogenous stress. Furthermore, the severity of the deficit was variable from one clone to another. Finally, not all ISC enzymes were affected in the hFXNI154F clones. Indeed, glutamine phosphoribosylpyrophosphate aminotranferase (GPAT), an enzyme of purine biosynthesis which requires the incorporation of a [4Fe-4S] cluster to generate the mature enzyme [33], is not affected in both the hFXNG130V and hFXNI154F clones (Fig. 5D), suggesting that some ISC enzymes are less sensitive to frataxin functional impairment.
###end p 31
###begin title 32
###xml 80 85 80 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 94 99 94 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
Biochemical measurements of ISC enzyme activities in wild-type hFXN, mutant hFXNG130V and hFXNI154F clones.
###end title 32
###begin p 33
###xml 1195 1200 1189 1194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 1208 1213 1202 1207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
A. Complex II of respiratory chain (Succinate Quinone DCPIP Reductase, SQDR; white bars) and aconitases (grey bars) specific activities were standardized to isocitrate dehydrogenase (IDH) specific activity and expressed as percentage of control activity. B. IRP1/IRE binding activity was measured by EMSA. Signals in the absence and in the presence of 2% of 2-betamercaptoethanol (betaME) were quantified to determine the percentage of IRE-binding IRP1 in each clone. C. Nth1 activity was determined by the thymidine glycol nicking activity of crude nuclear extracts of each clone. Results, expressed as percentage of control activity, are given as the mean of the quantified intensity of Nth1 cleaved product signal from the thymidine glycol containing oligo observed on a 20% denaturing polyacrylamide gel. D. Western blot analysis using a specific anti-GPAT antibody. GAPDH was used as a loading control. GPAT C1F represents COS cells expressing a mutated GPAT which cannot be maturated, giving the GPAT precursor migration size. All values were generated by determining the means of two or three independent experiments performed on different cell extracts on at least 3 clones of hFXN, hFXNG130V or hFXNI154F. Data are represented as mean + SD. * p<0.05; *** p<0.005.
###end p 33
###begin p 34
###xml 177 186 177 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.elegans</italic>
###xml 191 201 191 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 209 212 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Pandolfo1">[4]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Puccio2">[34]</xref>
###xml 497 502 497 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 511 516 511 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 602 609 602 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g006">Fig. 6A</xref>
###xml 629 634 629 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 784 789 780 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 842 847 838 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 856 863 852 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g006">Fig. 6A</xref>
###xml 887 892 883 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 953 958 949 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1038 1043 1034 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1110 1115 1106 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1161 1166 1157 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 1175 1180 1171 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1268 1275 1264 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g006">Fig. 6B</xref>
###xml 1354 1361 1350 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g006">Fig. 6C</xref>
###xml 1494 1501 1490 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g006">Fig. 6B</xref>
###xml 1613 1620 1609 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g002">Fig. 2A</xref>
###xml 1880 1885 1876 1881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 148 155 <span type="species:ncbi:9606">patient</span>
###xml 170 175 <span type="species:ncbi:4932">yeast</span>
###xml 177 186 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C.elegans</span>
###xml 191 201 <span type="species:ncbi:7227">Drosophila</span>
A recognized characteristic of frataxin deficiency is the increased susceptibility to induction of endogenous or exogenous oxidative stress in FRDA patient cells, and in yeast, C.elegans and Drosophila models [4], [34]. To investigate the oxidative status of the newly developed cell models, we monitored the presence of intracellular ROS (peroxides and peroxynitrite anion) using the dihydrorhodamine 123 probe. Comparison of oxidation-induced fluorescence of the probe by FACS between hFXN, hFXNG130V and hFXNI154F clones revealed no difference in the production of ROS in normal culture conditions (Fig. 6A). However, the hFXNI154F clones were more sensitive to exogenous stress, as a treatment with 10 microM hydrogen peroxide caused a drastic change in fluorescence level in hFXNI154F clones compared to moderate effects on hFXN and hFXNG130V clones (Fig. 6A). Furthermore, the hFXNI154F-2C1 clone had a lower susceptibility to stress than the hFXNI154F-1D3 clone since the fluorescence peak in the later was fully shifted. This hFXNI154F-2C1 clone appeared globally less affected than the two others hFXNI154F clones (1D3 and C6). Interestingly, both hFXNG130V and hFXNI154F clones displayed a significantly reduced catalase activity (44% and 51%, respectively, Fig. 6B) that correlated with a decrease in catalase expression at the protein level (Fig. 6C) and at the mRNA level (not shown). On the other hand, no significant change was observed in the activity of glutathione reductase (Fig. 6B). Furthermore, no difference in the mitochondrial superoxide dismutase (Sod2) expression at the protein level (Fig. 2A) or at the RNA level (data not shown) was observed. Overall, these results suggest that the combination of iron deregulation with a deficit in the antioxidant enzyme catalase could explain the susceptibility to exogenous oxidative stress observed for the hFXNI154F clones.
###end p 34
###begin title 35
###xml 85 90 85 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 99 104 99 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
ROS determination and antioxidative enzymes activities in wild-type hFXN, mutant hFXNG130V and hFXNI154F clones.
###end title 35
###begin p 36
###xml 396 401 392 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 410 415 406 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 489 494 485 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 517 522 513 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
A. FACS analysis of cells incubated with DHR123. The dashed curve represents the autofluorescence of fibroblasts cells without DHR123 treatment. The black curve represents the observed fluorescence in cells in endogenous conditions and the grey curve is the fluorescence induced after hydrogen peroxide incubation (10 microM; 30 min). Experiments were done in triplicate on 3 clones of hFXN, hFXNG130V and hFXNI154F. Results show one representative diagram from one clone for hFXN and hFXNG130V, and 2 clones for hFXNI154F. B. Enzymatic actvities of catalase (grey bars) and glutathione reductase (black bars) were determined spectrophotometrically. Activities are presented as the percentage of WT hFXN clones activity. Data are represented as mean + SD. * p<0.05. C. Catalase protein was detected using an anti-catalase antibody and compared to GAPDH as a loading control.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 520 528 520 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 434 440 <span type="species:ncbi:10090">murine</span>
###xml 452 457 <span type="species:ncbi:9606">human</span>
###xml 620 626 <span type="species:ncbi:10090">murine</span>
###xml 678 683 <span type="species:ncbi:9606">human</span>
###xml 783 791 <span type="species:ncbi:9606">patients</span>
###xml 941 949 <span type="species:ncbi:9606">patients</span>
In the present study, we report the first cellular models for FRDA based on pathological missense mutations which spontaneously show all the biochemical features of the human disease. Using a fluorescent Cre recombinase in fibroblasts carrying the conditional frataxin allele, we first demonstrated that complete frataxin deficiency in a fibroblast cell line does not sustain cell division and survival. Both transgenic expression of murine (mFxn) and human frataxin (hFXN) can rescue this lethality. Through this novel in vitro system, we generated two humanized cell models by combining the deletion of the endogenous murine conditional frataxin allele with the expression of human frataxin carrying either the G130V or I154F missense mutations found in compound heterozygous FRDA patients. Of interest, the two humanized cell models show different severities in their phenotype, which correlate with the disease severity observed in FRDA patients.
###end p 38
###begin p 39
###xml 19 23 19 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Pook1">[35]</xref>
###xml 25 29 25 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Sarsero1">[36]</xref>
###xml 194 199 194 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 208 213 208 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 383 388 383 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 397 402 397 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 631 637 631 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> I154F</sup>
###xml 1036 1039 1036 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Puccio1">[7]</xref>
###xml 1041 1045 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Simon1">[37]</xref>
###xml 1093 1097 1093 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Zanella1">[30]</xref>
###xml 1277 1282 1277 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1502 1505 1502 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Martelli1">[8]</xref>
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
###xml 304 309 <span type="species:ncbi:9606">human</span>
###xml 1023 1028 <span type="species:ncbi:10090">mouse</span>
###xml 1355 1360 <span type="species:ncbi:10090">mouse</span>
###xml 1639 1644 <span type="species:ncbi:10090">mouse</span>
As in mouse models [35], [36], hFXN can fully substitute for mFxn at the cellular level. Indeed, the hFXN clones show no morphological or biochemical alterations. In contrast, although both hFXNG130V and hFXNI154F can rescue the lethality of complete mFxn deficient cells, the sole expression of mutated human frataxin does not fully restore functional mitochondria. Indeed, the hFXNG130V and hFXNI154F mutant clones show degenerating mitochondria with disorganized cristae and electron-dense deposits, and a specific deficit in mitochondrial ISC enzymes activities, which are features characteristic of FRDA. In addition, the hFXN I154F clones exhibit a deficit in the nuclear ISC cluster DNA glycosylase, Nth1, a dysregulated IRP1 IRE-binding activity, an increased mitochondrial iron content, and an increased susceptibility to exogenous oxidative stress. Interestingly, not all ISC enzymes are affected equivalently by frataxin deficiency. As previously reported in the nervous tissues of conditional frataxin knockout mouse models [7], [37] as well as in Hela cells silenced for frataxin [30], the activity of SDH is more affected than the activity of the mitochondrial aconitase. In addition, GPAT maturation which requires an ISC, is not affected in the more severe hFXNI154F clones. This observation is in agreement with data from the conditional mouse models that suggest a threshold effect of ISC enzyme activities that is both tissue-specific as well as dependent on the disease progression [8]. Indeed, the new "humanized" cell models that we are reporting present a milder ISC enzymes deficiency than the conditional knockout mouse models. These results suggest that the affected tissues in FRDA should not present a deficiency in all ISC enzymes. It will be of interest in the future to uncover which ISC enzymes participate in the pathology of the different tissues.
###end p 39
###begin p 40
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-ChantrelGroussard1">[38]</xref>
###xml 578 582 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Lobmayr1">[39]</xref>
###xml 602 607 602 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 729 733 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Paupe1">[40]</xref>
###xml 734 738 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Tan2">[42]</xref>
###xml 798 803 798 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 870 874 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-ChantrelGroussard1">[38]</xref>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Tan2">[42]</xref>
###xml 881 885 881 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Wong1">[44]</xref>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 504 512 <span type="species:ncbi:9606">patients</span>
The "humanized" cell models developed are a valuable addition to the available cellular models for FRDA research. Indeed, in contrast to fibroblasts or lymphocytes cell lines from FRDA patients, which show a large variability and a lack of reproducibility depending on the culture conditons, the biochemical phenotype of the "humanized" cell models is stable over multiple passages. Furthermore, the "humanized" cell models spontaneously exhibit multiple ISC enzymes deficit, while fibroblasts from FRDA patients present an ISC enzymes deficit only under exogenous stress [38], [39]. Moreover, the hFXNI154F clones present a clear 2.3 fold increased in mitochondrial iron, a feature not found in FRDA fibroblasts nor lymphocytes [40]-[42]. A common feature between the FRDA fibroblasts and the hFXNI154F clones is the increased sensitivity to exogenous oxidative stress [38], [42]-[44]. Therefore, as both the G130V and I154F mutant clones display a stable and spontaneous biochemical phenotype and are able to proliferate in classical culture conditions, these new cellular models will be useful for functional-based large-scale drug screening.
###end p 40
###begin p 41
###xml 151 156 151 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 220 225 220 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 390 395 390 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 541 546 541 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 667 672 667 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 716 721 716 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 784 789 784 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 43 49 <span type="species:ncbi:10090">murine</span>
The pathological missense mutations affect murine fibroblasts in a manner that correlates with the disease severity in compound heterozygotes. The hFXNG130V mutant appears more efficient to rescue lethality than the hFXNI154F mutant although neither clone completely rescues the phenotype. The global morphological alterations as well as the ISC enzymes deficits are less severe in the hFXNG130V clones. Furthermore, the ultrastructural abnormalities in mitochondria as well as intramitochondrial iron deposits were more frequent in the hFXNI154F mutants and a growth defect was only observed in this more severe model. We observed a high expression level of the hFXNI154F transgene compared to the wild-type or hFXNG130V mutant, pointing to a severe functional impairment of the hFXNI154F protein. Indeed, during the clonal selection, only cells expressing high copy number of this severe mutant were able to undergo cell proliferation.
###end p 41
###begin p 42
###xml 70 75 70 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 307 308 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 309 310 309 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 392 402 392 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Anderson2">[45]</xref>
###xml 766 767 766 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 768 769 768 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 873 878 873 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 982 987 982 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 1189 1193 1189 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Paupe1">[40]</xref>
###xml 392 402 <span type="species:ncbi:7227">Drosophila</span>
The increased susceptibility to exogenous oxidative stress of the hFXNI154F clones probably arises from strong iron homeostasis dysregulation in conjunction with a decreased activity of the antioxidant enzyme, catalase. Recently, Anderson et al. have shown that ectopic expression of enzymes that scavenge H202 (peroxisomal and mitochondrial catalases and a mitochondrial peroxiredoxin) in a Drosophila model deficient for frataxin suppresses some of the deleterious phenotypes associated with frataxin deficiency, while overexpression of enzymes that scavenge superoxides (SOD1 and SOD2) have no effect [45]. The present results further support the notion that the increased susceptibility of frataxin deficient cells is linked to an impaired capacity to detoxify H202, although the sole impairment of catalase is not sufficient to result in increased susceptibility (hFXNG130V clones). Finally, it would be of interest to test the potential effect of catalase mimetics on the hFXNI154F cellular model. Indeed, a recent study demonstrate that a catalase mimetic can restore the responsiveness of the Nrf2-dependent signaling pathway to induced oxidative stress in frataxin-depleted cells [40].
###end p 42
###begin p 43
###xml 245 250 245 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G130V</sup>
###xml 259 264 259 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Correia1">[46]</xref>
###xml 489 494 489 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I154F</sup>
###xml 543 547 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Correia1">[46]</xref>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Correia2">[47]</xref>
###xml 628 635 628 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 712 720 712 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 778 785 778 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 171 176 <span type="species:ncbi:9606">human</span>
The genotype-phenotype correlation observed in our cell models is not fully explained by structural and functional studies. A comparative study of the protein dynamics of human frataxin variants has revealed that although destabilized, both hFXNG130V and hFXNI154F mutant proteins should be properly folded in physiological conditions [46]. However, the two frataxin variants show different iron binding properties. While the G130V mutation decreases iron affinity of the protein, the hFXNI154F mutant protein precipitates in presence of iron [46], [47]. The models that we have developed constitute powerful tools to study the in vivo properties of the two mutant proteins, and to test whether the differential in vitro iron binding property of the mutant proteins is relevant in vivo.
###end p 43
###begin p 44
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Klinge1">[48]</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Chen1">[49]</xref>
In addition, our results show for the first time that complete frataxin deficiency in a fibroblast cell line does not sustain cell division and survival. The deficit in the activity of the respiratory chain complexes alone may not explain the severity of the phenotype, as fibroblasts carrying mitochondrial respiratory chain deficiency are viable in culture. It is therefore tempting to speculate that the phenotype associated with complete deficiency of frataxin in fibroblast is linked to the deficit of alternative essential ISC proteins, such as the eukaryotic primase [48], necessary for DNA replication, and the ABCE1 protein [49], essential for translation initiation and ribosome maturation. Further investigations to test these hypotheses are however difficult due to the paucity of these frataxin deficient cells.
###end p 44
###begin p 45
###xml 362 370 362 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
While some pharmacological compounds have shown some promising results in clinical trials in providing protection on certain aspects of the disease, there is still no effective therapy for FRDA. A valuable therapeutic approach would be frataxin replacement either by gene therapy or by protein replacement using protein transduction domains. We believe that the in vitro system that we have generated will provide a powerful tool to functionally evaluate frataxin protein delivery methods or frataxin replacement therapeutic strategies.
###end p 45
###begin title 46
Materials and Methods
###end title 46
###begin title 47
Plasmid constructs, molecular analysis, and mitochondrial-enriched fraction
###end title 47
###begin p 48
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Koutnikova1">[50]</xref>
###xml 499 503 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Koutnikova1">[50]</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Campuzano2">[51]</xref>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BglII</italic>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoRI</italic>
###xml 854 857 854 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Puccio1">[7]</xref>
###xml 1005 1008 1005 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Puccio1">[7]</xref>
###xml 1010 1013 1010 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Martelli1">[8]</xref>
###xml 1015 1018 1015 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Seznec1">[9]</xref>
###xml 1151 1158 1151 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006379.s001">Text S1</xref>
###xml 1273 1277 1273 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-AyalaTorres1">[52]</xref>
###xml 1369 1373 1369 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Schmucker1">[53]</xref>
###xml 1495 1498 1495 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Martelli1">[8]</xref>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 250 255 <span type="species:ncbi:9606">human</span>
###xml 609 625 <span type="species:ncbi:10678">bacteriophage P1</span>
###xml 882 887 <span type="species:ncbi:10090">mouse</span>
###xml 1041 1046 <span type="species:ncbi:9606">human</span>
###xml 1084 1089 <span type="species:ncbi:10090">mouse</span>
The complete coding sequence (nucleotide sequence 1-624) xof mouse frataxin (mFxn) was subcloned from the pTL1 vector [50] to the pSG5-Puro-Flag vector (modified from pSG5 vector, Stratagene) by enzymatic restriction. The complete coding sequence of human frataxin (hFXN) wild-type (nucleotide sequence 1-632), C-terminal truncated form encoding exons 1 and 2 only (nucleotide sequence 1-263) and full length hFXN carrying the G130V and I154F missense mutations were subcloned from the pTL1 vectors [50], [51] to the pcDNA 3.1/Zeo (Invitrogen) vector either by enzymatic restriction or PCR. The cDNA encoding bacteriophage P1 Cre recombinase was cloned between the BglII and EcoRI restriction sites of pEGFP-C2 (Clontech), in frame with and 3' to the EGFP cDNA. All constructs were checked by sequencing. Genotyping was performed as previously described [7]. Quantitative RT-PCR of mouse frataxin, hprt, Sod1, Sod2, and Nth1 transcripts were performed on a LightCycler 480 (Roche) as previously described [7], [8], [9]. Amplification of the human frataxin-specific transcript and the mouse catalase transcript was performed using primers described in Text S1. The integrity of mitochondrial DNA was checked by large-fragment PCR using primers (3278 and 13337) as described [52]. Total protein extract and mitochondria-enriched fractions obtained by digitonin treatment [53] were analyzed on SDS-Glycine-PAGE (10-13.5% acrylamide). Western blot and antibody dilution were as previously described [8].
###end p 48
###begin title 49
Cell culture, transfection, and FACS sorting
###end title 49
###begin p 50
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Frda</italic>
###xml 59 64 59 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L3/L-</sup>
###xml 72 79 72 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006379-g001">Fig. 1A</xref>
###xml 81 84 81 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Puccio1">[7]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Freshney1">[54]</xref>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:9913">calf</span>
Murine fibroblast cultures from frataxin heterozygous (FrdaL3/L-) mice (Fig. 1A) [7] were established using the primary-explant technique [54], and immortalized by transfection with a Large Antigen T construct. All transfections were performed using the Fugene 6 Transfection Reagent kit (Roche). Stably transfected fibroblasts were grown in DMEM media (Sigma, Saint Louis, Missouri) with 10% fetal calf serum and 50 microg/ml gentamycin, supplemented either with puromycin (5 microg/ml) or zeocin (250 microg/ml). Antibiotic selection was maintained for one month to obtain stable cell lines.
###end p 50
###begin p 51
Cell sorting was performed 48 hrs after transfection. Trypsinised cells were resuspended in PBS and filtered through a 50 microm sterile mesh (BD Biosciences), and were then sorted for EGFP expression on a FACSDiVa Vantage (Becton-Dickinson). EGFP positive cells were either isolated one cell per well in 96-well plates filled with conditional medium or collected all together (population).
###end p 51
###begin title 52
Phase contrast, crystal violet staining, and electron microscopy
###end title 52
###begin p 53
Cells were fixed with methanol and stained with crystal violet 0.1%. Living cell cultures and stained cells were observed using a Leica DMLB inverted microscope with Hoffman contrast (LMC) (10x magnification) or phase contrast (20x magnification) and photographs were taken by a CoolSnap camera. For electron microscopy, cellular clones were fixed in a freshly made mixture of 2.5% paraformaldehyde and 2.5% glutaraldehyde in cacodylate buffer (0.1 M, pH 7.2), rinsed in cacodylate buffer, postfixed in 1% osmium tetroxide in 0.1 M cacodylate buffer for 1 hour at 4degreesC, dehydrated, and embedded in Epon. Ultrathin sections were cut at 70 nm and contrasted with uranyl acetate and lead citrate and examined with a Morgagni 268D electron microscope. Three to five clones were analyzed from each cell line.
###end p 53
###begin title 54
Biochemical analyses
###end title 54
###begin p 55
###xml 128 131 128 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Puccio1">[7]</xref>
###xml 302 308 302 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> G130V</sup>
###xml 323 329 323 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> I154F</sup>
###xml 385 388 385 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Martelli1">[8]</xref>
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Kim1">[55]</xref>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006379.s001">Text S1</xref>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Aebi1">[56]</xref>
The activities of the succinate dehydrogenase (SDH), aconitases and isocitrate dehydrogenase (IDH) were as previously described [7]. The specific activities of SDH and aconitases were reported to the specific activity of IDH. Three independent measurements were performed on four hFXN clones, five hFXN G130V and three hFXN I154F mutant clones. Nth1 activity was assessed as described [8]. The IPR1 IRE-binding activities were assessed by EMSA as previously described [55] with some modifications as described in Text S1. The activity of catalase was determined spectrophotometrically as described [56] by measuring the absorbance decrease at 240 nm in a 20 mM phosphate buffer pH 7 containing 10 mM of hydrogen peroxide. The glutathione reductase activity assays were carried out in phosphate buffer (pH 7.4; 0.1 M) which contains 0.5 mM EDTA and 1 mM of oxidized glutathione at 37degreesC. The reaction was initiated by adding 0.2 mM of NADPH (SIGMA). Activity was determined by following the disappearance of NADPH at 340 nm.
###end p 55
###begin title 56
Iron measurements
###end title 56
###begin p 57
###xml 666 668 660 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 671 673 665 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 690 694 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006379-Moulis1">[57]</xref>
Mitochondrial-enriched extracts were mixed with 0.3 volume of HCl 12N and incubated at 40degreesC for 1 hour. Distilled water was added and precipitated material was removed by centrifugation at 15,000 g, 10 min. The samples were diluted with Tris-base 1 M pH 8.8 and incubated in presence of ascorbic acid 0.25% and bathophenanthroline disulfonic acid 0.02% (Sigma) for 1 hour in the dark. The absorbance at 535 nm of the iron/bathophenanthroline disulfonate complex was measured against a blank containing mitochondrial extract, buffer and reagents without bathophenanthroline. The iron concentration was determined using a molar extinction coefficient of 22,140 M-1.cm-1 for the complex [57]. For the atomic absorption spectroscopy, mitochondria-enriched fractions were lysed with Tris 0.1 M pH 7.5, Triton X-100 0.5% and mitochondrial soluble fraction was separated from the membrane insoluble pellet by centrifugation 12,000 g, 10 min at 4degreesC. Supernatant were diluted in pure water (18 MOmega) containing 0.2% nitric acid. The pellets were dissolved in 1 ml of pure nitric acid. The calibration of the iron concentration was done by using standard iron solutions for atomic absorption purchased from Fluka. The graphite furnace used was a Perkin-Elmer 4110ZL spectrometer equipped with an autosampler AS-72.
###end p 57
###begin title 58
Reactive Oxygen Species (ROS) determination
###end title 58
###begin p 59
The presence of cellular ROS was assessed by using the redox sensitive probe DiHydroRhodamine 123 (DHR123, Molecular Probes). Fibroblasts (60-80% of confluency) were incubated with 30 microM of DHR123 at 37degreesC for 15 min, washed twice with PBS and incubated 30 min at 37degreesC in PBS supplemented or not by 10 microM of hydrogen peroxide. Cells were then treated with trypsin, centrifuged at 1000 g, 5 min in culture medium and washed with PBS. The fluorescence intensity of cells was analysed by flow cytometric analysis in a FACScalibur (Becton-Dickinson; FL-1, band pass filter 530/30 nm). Data were analysed by Flowjo.
###end p 59
###begin title 60
Statistics
###end title 60
###begin p 61
All data represent mean+/-SD. Statistical analyses were performed by standard Student t-test. Statistical significance was considered at p<0.05.
###end p 61
###begin title 62
Supporting Information
###end title 62
###begin p 63
(0.04 MB DOC)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine frataxin protein level in FrdaL-/L- transfected clones. Frataxin protein level in transfected clones. Western Blot analysis of total protein extracts from FrdaL3/L- non-transfected cell line (NT), the FrdaL3/L-; empty growing clone F8, and four FrdaL3/L-; mFxn clones (B6, H5, C10 and E2) using a polyclonal frataxin antibody. beta-tubulin detection was used to assess equal loading in each lane. Note that in the F8 clone, we detect endogenous frataxin confirming its non-deleted status.
###end p 65
###begin p 66
(1.72 MB TIF)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
Morphology of frataxin deficient clones by electron microscopy. Frataxin deleted cells show very little ultrastructural changes. Apart from the retraction of the plasma membrane, no structural anomaly or sign of necrosis or apoptosis was observed in FrdaL3/L-; empty clone (C and D) compared to FrdaL3/L-; mFxn clone (A and B) after six days of culture. No mitochondrial dense material suggestive of iron deposit has been observed. Lp, lipid droplet; mt, mitochondria; N, nucleus; nu, nucleole.
###end p 68
###begin p 69
(1.05 MB PDF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
###xml 290 295 <span type="species:ncbi:4679">onion</span>
Ultrastructural alterations in hFXNG130V and hFXNI154F clones. Electron microscopy on hFXN (A), hFXNI154F (B) and hFXNG130V (C,D) clones. b, plasma membrane blebbing; g-mt, giant mitochondria; Lp, lipid droplet; mt, mitochondria; mt-Fe, intramitochondrial iron deposits; N, nucleus; os-mt, onion-shaped mitochondria; p, pseudopodia; rer, rough endoplasmic reticulum.
###end p 71
###begin p 72
(1.76 MB TIF)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
###xml 237 257 237 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">material and methods</xref>
Iron content of hFXN, hFXNG130V and hFXNI154F clones determined by atomic absorption spectroscopy. Mitochondrial soluble fraction or insoluble membrane pellet iron contents were assessed by atomic absorption spectroscopy as described in material and methods. Results are given as mean of microg of iron per mg of protein in each fraction + SD. * p<0.05.
###end p 74
###begin p 75
(9.44 MB TIF)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
We thank G. Scherrer and B. Kieffer for the generous gift of the pEGFP-Cre plasmid, and T.L. Lai (CEA-Saclay) for the atomic absorption spectroscopy measurements.
###end p 77
###begin title 78
References
###end title 78
###begin article-title 79
Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features.
###end article-title 79
###begin article-title 80
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up.
###end article-title 80
###begin article-title 81
Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.
###end article-title 81
###begin article-title 82
The pathogenesis of Friedreich ataxia and the structure and function of frataxin.
###end article-title 82
###begin article-title 83
Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.
###end article-title 83
###begin article-title 84
Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia.
###end article-title 84
###begin article-title 85
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits.
###end article-title 85
###begin article-title 86
Frataxin is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues.
###end article-title 86
###begin article-title 87
Friedreich ataxia: the oxidative stress paradox.
###end article-title 87
###begin article-title 88
###xml 31 41 <span type="species:ncbi:111938">gatekeeper</span>
Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS.
###end article-title 88
###begin article-title 89
Sticky DNA, a self-associated complex formed at long GAA*TTC repeats in intron 1 of the frataxin gene, inhibits transcription.
###end article-title 89
###begin article-title 90
DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing.
###end article-title 90
###begin article-title 91
###xml 14 34 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
Deficiency of Arabidopsis thaliana frataxin alters activity of mitochondrial Fe-S proteins and induces oxidative stress.
###end article-title 91
###begin article-title 92
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation.
###end article-title 92
###begin article-title 93
###xml 11 21 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
Long-lived C. elegans mitochondrial mutants as a model for human mitochondrial-associated diseases.
###end article-title 93
###begin article-title 94
###xml 76 86 <span type="species:ncbi:7227">Drosophila</span>
RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila.
###end article-title 94
###begin article-title 95
###xml 40 50 <span type="species:ncbi:7227">Drosophila</span>
Causative role of oxidative stress in a Drosophila model of Friedreich ataxia.
###end article-title 95
###begin article-title 96
Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes.
###end article-title 96
###begin article-title 97
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Frataxin gene point mutations in Italian Friedreich ataxia patients.
###end article-title 97
###begin article-title 98
###xml 21 26 <span type="species:ncbi:9606">human</span>
Crystal structure of human frataxin.
###end article-title 98
###begin article-title 99
Towards a structural understanding of Friedreich's ataxia: the solution structure of frataxin.
###end article-title 99
###begin article-title 100
The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia.
###end article-title 100
###begin article-title 101
Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion.
###end article-title 101
###begin article-title 102
The correlation of clinical phenotype in Friedreich ataxia with the site of point mutations in the FRDA gene.
###end article-title 102
###begin article-title 103
Intrafamilial phenotypic variability in Friedreich ataxia associated with a G130V mutation in the FRDA gene.
###end article-title 103
###begin article-title 104
Frataxin knockdown causes loss of cytoplasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts.
###end article-title 104
###begin article-title 105
Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells.
###end article-title 105
###begin article-title 106
###xml 34 39 <span type="species:ncbi:9606">human</span>
Iron-sulfur protein maturation in human cells: evidence for a function of frataxin.
###end article-title 106
###begin article-title 107
Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells.
###end article-title 107
###begin article-title 108
###xml 81 86 <span type="species:ncbi:9606">human</span>
The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin.
###end article-title 108
###begin article-title 109
Iron regulatory proteins and the molecular control of mammalian iron metabolism.
###end article-title 109
###begin article-title 110
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human DNA glycosylases involved in the repair of oxidatively damaged DNA.
###end article-title 110
###begin article-title 111
Avian glutamine phosphoribosylpyrophosphate amidotransferase propeptide processing and activity are dependent upon essential cysteine residues.
###end article-title 111
###begin article-title 112
Multicellular models of Friedreich ataxia.
###end article-title 112
###begin article-title 113
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
###xml 52 57 <span type="species:ncbi:9606">human</span>
Rescue of the Friedreich's ataxia knockout mouse by human YAC transgenesis.
###end article-title 113
###begin article-title 114
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 72 87 <span type="species:ncbi:10090">transgenic mice</span>
Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice.
###end article-title 114
###begin article-title 115
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia.
###end article-title 115
###begin article-title 116
Disabled early recruitment of antioxidant defenses in Friedreich's ataxia.
###end article-title 116
###begin article-title 117
Increased IRP1 activity in Friedreich ataxia.
###end article-title 117
###begin article-title 118
Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia.
###end article-title 118
###begin article-title 119
###xml 64 69 <span type="species:ncbi:9606">human</span>
Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?
###end article-title 119
###begin article-title 120
Frataxin expression rescues mitochondrial dysfunctions in FRDA cells.
###end article-title 120
###begin article-title 121
A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy.
###end article-title 121
###begin article-title 122
The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis.
###end article-title 122
###begin article-title 123
###xml 62 72 <span type="species:ncbi:7227">Drosophila</span>
Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia.
###end article-title 123
###begin article-title 124
Dynamics, stability and iron-binding activity of frataxin clinical mutants.
###end article-title 124
###begin article-title 125
###xml 28 33 <span type="species:ncbi:9606">human</span>
Conformational stability of human frataxin and effect of Friedreich's ataxia-related mutations on protein folding.
###end article-title 125
###begin article-title 126
An iron-sulfur domain of the eukaryotic primase is essential for RNA primer synthesis.
###end article-title 126
###begin article-title 127
The essential vertebrate ABCE1 protein interacts with eukaryotic initiation factors.
###end article-title 127
###begin article-title 128
Maturation of wild-type and mutated frataxin by the mitochondrial processing peptidase.
###end article-title 128
###begin article-title 129
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes.
###end article-title 129
###begin article-title 130
Analysis of gene-specific DNA damage and repair using quantitative polymerase chain reaction.
###end article-title 130
###begin article-title 131
###xml 49 54 <span type="species:ncbi:9606">human</span>
The in vivo mitochondrial two-step maturation of human frataxin.
###end article-title 131
###begin article-title 132
Culture of animal cells: a manual of basic technique:
###end article-title 132
###begin article-title 133
Control of transferrin receptor expression via nitric oxide-mediated modulation of iron-regulatory protein 2.
###end article-title 133
###begin article-title 134
The role of enzyme variants, polymorphisms and enzyme hybrids in enzyme deficiency conditions.
###end article-title 134
###begin article-title 135
###xml 73 97 <span type="species:ncbi:1501">Clostridium pasteurianum</span>
Characterization of the selenium-substituted 2 [4Fe-4Se] ferredoxin from Clostridium pasteurianum.
###end article-title 135
###begin p 136
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 136
###begin p 137
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by the French National Agency for Research (ANR-05-MRAR-013-01), the French Ministry for Research (ACI-JC5375), the French Medical Research Foundation "Equipe FRM 2005" (DEQ-1205774) and the Hopitaux Universitaires de Strasbourg (HUS). S.S is supported by the French Ministry for Research, M.W.D. by the Association Francaise de l'Ataxie de Friedreich (AFAF), and A.M. by Friedreich Ataxia Research Alliance (FARA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 137

